期刊文献+

脓毒症和心肌线粒体损伤 被引量:27

下载PDF
导出
摘要 脓毒症为全身性的炎症反应,是重症加强治疗病房(ICU)患者的主要死亡原因。大约有40%~50%的脓毒症患者会合并心脏功能不全,其中出现严重心功能衰竭(心衰)者约7%。迄今为止,其发生机制尚无定论。细菌毒素、细胞因子等通过不同途径造成心肌灌注不足、心肌能量代谢障碍以及心肌细胞凋亡等被认为是脓毒症导致心脏损伤的重要机制,心肌能量代谢障碍是其中的关键机制。心肌线粒体是心肌能量代谢的主要场所,脓毒症时心肌线粒体也发生了一系列变化,主要从以下几个方面导致心肌损伤。
出处 《中国危重病急救医学》 CAS CSCD 北大核心 2007年第10期630-632,共3页 Chinese Critical Care Medicine
基金 卫生部科研基金一浙江省医药卫生重大科研项目(WKJ2005-2-035)
  • 相关文献

参考文献21

  • 1Angus D C,Linde-Zwirble W T,Lidicker J,et al. Epidemiology of severe sepsis in the United States:analysis of incidence,outcome,and associated costs of care[J]. Crit Care Med ,2001,29 (7) : 1303 - 1310.
  • 2Court O, Kumar A, Parrillo J E, et al. Clinical review: myocardial depression in sepsis and septic shock [J]. Crit Care, 2002,6(6) :500 - 508.
  • 3Paradies G, Petrosillo G, Pistolese M, et al. Lipid peroxidation and alterations to oxidative metabolism in mitochondria isolated from rat heart subjected to ischemia and reperfusion [J]. Free Radic Biol Med, 1999,27 (1 - 2) : 42 - 50.
  • 4Zang Q, Maass D L, Tsai S J, et al. Cardiac mitochondrial damage and inflammation responses in sepsis [J]. Surg Infect (Larchmt) ,2007,8(1) : 41 - 54.
  • 5Parratt J R. Nitric oxide in sepsis and endotoxaemia[J]. J Antimicrob Chemother,1998,41(Suppl A):31 - 39.
  • 6Thompson M,Kliewer A, Maass D, et al. Increased cardiomyocyte intracellular calcium during endotoxin - induced cardiac dysfunction in guinea pig [J]. Pediatr Res, 2000,47(5) :669 - 676.
  • 7Boya P, Roques B, Kroemer G. New EMBO members' review:viral and bacterial proteins regulating apoptosis at the mitochondrial level [J]. EMBO J, 2001,20(16) :4325 - 4331.
  • 8明自强,俞林明,吕银祥,吕少明,王黎卫,王映红.脓毒症患者氧利用率的变化与预后关系[J].中国中西医结合急救杂志,2006,13(4):247-249. 被引量:3
  • 9Brigold U, Ghafourifar P, Richter C. Peroxynitrite formed by mitochondrial NO synthase promotes mitochondrial Ca^2z+ release [J]. Free Radic Biol Med, 2000,29(3- 4) :343- 348.
  • 10隰建成,周宝桐.脓毒症过程中的炎症介质与细胞凋亡关系的研究进展[J].中国危重病急救医学,2000,12(6):378-380. 被引量:7

二级参考文献21

  • 1Ayala A,Blood,1998年,91卷,4期,1362页
  • 2Le Quan,J Immunol,1998年,160卷,7期,3330页
  • 3Wang Jianghuai,Am J Physiol,1995年,269卷,2pt1期,G297页
  • 4Balk R A.Pathogenesis and management of multiple organ dysfunction or failure in severesepsis and septic shock[J].Crit Care Clin,2000,16:337-352.
  • 5Bone R C,Balk R A,Cerra F B,et al.Definitions for sepsis and organ failure andguidelines for the use of innovative therapies in sepsis.The ACCP/SCCM ConsensusConference Committee American College of Chest Physician/Society of Critical CareMedicine[J].Chest,1992,101:1644-1655.
  • 6Tracey K J,Lowry S F,Cerami A.Cachetin/TNF-alpha in septic shock and septic adultrespirate distress Syndrome[J].Am Rev Respir Dis,1998,138:1377-1379.
  • 7Schmidt C R,Frank L P,Forsythe S B,et al.Continuous S-vO2 measurement and oxygentransport patterns in cardiac surgery patients[J].Crit Care med,1984,12:523-527.
  • 8Oku K,Kuboyama K,Safar P,et al.Cerebral and systemic arteriovenous oxygen monitoringafter cardiac arrest:inadequate cerebral oxygen delivery[J].Resuscitation,1994,27:141-152.
  • 9Dellinger R P, Carlet J M, Masur H, et al. Surviving sepsis campaign guidelines for management of severe sepsis and sepsis shock [J]. Crit Care Med, 2004,32 : 858 - 873.
  • 10Hinshaw L B. Sepsis/septic shock:participation of the microcirculation: an abbreviated review [J]. Crit Care Med, 1996,24 :1072 - 1078.

共引文献13

同被引文献301

引证文献27

二级引证文献244

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部